Birgitte Volck
Director/Board Member at SOLENO THERAPEUTICS, INC.
Net worth: 301 526 $ as of 2024-03-30
Birgitte Volck active positions
Companies | Position | Start | End |
---|---|---|---|
SOLENO THERAPEUTICS, INC. | Director/Board Member | 2019-06-09 | - |
Independent Dir/Board Member | 2019-06-09 | - | |
NYKODE THERAPEUTICS | Director/Board Member | 2021-05-04 | - |
Career history of Birgitte Volck
Former positions of Birgitte Volck
Companies | Position | Start | End |
---|---|---|---|
ASCENDIS PHARMA A/S | Director/Board Member | 2016-04-30 | 2021-07-11 |
Chief Tech/Sci/R&D Officer | 2021-07-11 | 2023-11-30 | |
Independent Dir/Board Member | 2016-04-30 | 2021-07-11 | |
AVROBIO, INC. | Chief Tech/Sci/R&D Officer | 2018-11-30 | 2020-09-30 |
TFS Trial Form Support AB
TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Director/Board Member | 2016-04-30 | 2019-12-31 |
GSK PLC | Chief Tech/Sci/R&D Officer | 2016-05-31 | 2018-07-31 |
WILSON THERAPEUTICS AB | Director/Board Member | 2017-05-21 | 2018-04-30 |
Independent Dir/Board Member | 2017-05-21 | 2018-04-30 | |
SWEDISH ORPHAN BIOVITRUM AB | Chief Tech/Sci/R&D Officer | 2012-07-31 | 2015-12-31 |
AMGEN INC. | Corporate Officer/Principal | 2006-12-31 | 2012-06-30 |
░░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░ ░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
Training of Birgitte Volck
University of Copenhagen | Doctorate Degree |
Statistics
International
Denmark | 5 |
Sweden | 5 |
United States | 4 |
Operational
Director/Board Member | 6 |
Chief Tech/Sci/R&D Officer | 5 |
Independent Dir/Board Member | 3 |
Sectoral
Health Technology | 10 |
Commercial Services | 3 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 7 |
---|---|
AMGEN INC. | Health Technology |
SOLENO THERAPEUTICS, INC. | Health Technology |
GSK PLC | Health Technology |
ASCENDIS PHARMA A/S | Health Technology |
NYKODE THERAPEUTICS | Health Technology |
SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
AVROBIO, INC. | Health Technology |
Private companies | 5 |
---|---|
Pharmexa A/S
Pharmexa A/S Pharmaceuticals: MajorHealth Technology Pharmexa A/S is a leading company in the field of active immunotherapy for the treatment of serious chronic diseases. Pharmexa's proprietary AutoVac(tm) technology platform is broadly applicable, but the company has focused its resources on a number of cancer forms and chronic inflammatory diseases, with research and development programs targeted towards breast cancer, rheumatoid arthritis and bone degeneration | Health Technology |
TFS Trial Form Support AB
TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support AB provides clinical trial services. The firm operates as a clinical contract research organization. Its services include regulatory affairs, feasibility, global clinical operations, study and site coordination, patient recruitment services, clinical data management, edc systems, biostatistics, pharmacovigilance/safety, medical writing, quality assurance, tfs academy, and functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lund, Sweden. | Commercial Services |
TFS Trial Form Support International AB
TFS Trial Form Support International AB Miscellaneous Commercial ServicesCommercial Services TFS Trial Form Support International AB provides clinical contract research services. It offers clinical development planning, regulatory affairs, medical informatics, study and site coordination, clinical data management, biostatistics, medical writing, and other functional service solutions. The company was founded by Daniel Spasic in 1996 and is headquartered in Lud, Sweden. | Commercial Services |
Genzyme Danmark | |
Wilson Therapeutics AB
Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Wilson Therapeutics AB engages in the development of novel therapies for patients with rare copper-mediated disorders. The company was founded on April 25, 2012 and is headquartered in Stockholm, Sweden. | Health Technology |
- Stock Market
- Insiders
- Birgitte Volck
- Experience